ATE378062T1 - Mischmicell-arzneistoffverabreichungssystem und verfahren zu dessen herstellung - Google Patents

Mischmicell-arzneistoffverabreichungssystem und verfahren zu dessen herstellung

Info

Publication number: ATE378062T1
Authority: AT; Austria
Prior art keywords: acid; absorption enhancing; enhancing compounds; formulation; pharmaceutically acceptable
Prior art date: 1998-02-10

Application number

AT99904638T

Other languages

English (en)

Inventor

Pankaj Modi

Original Assignee

Generex Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-10

Filing date

1999-02-05

Publication date

2007-11-15

1999-02-05 Application filed by Generex Pharm Inc filed Critical Generex Pharm Inc

2007-11-15 Application granted granted Critical

2007-11-15 Publication of ATE378062T1 publication Critical patent/ATE378062T1/de

Links

238000012377 drug delivery Methods 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
238000010521 absorption reaction Methods 0.000 abstract 4
150000001875 compounds Chemical class 0.000 abstract 4
230000002708 enhancing effect Effects 0.000 abstract 4
239000000203 mixture Substances 0.000 abstract 3
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical class OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 2
229910052783 alkali metal Inorganic materials 0.000 abstract 2
-1 alkali metal salicylate Chemical class 0.000 abstract 2
238000009472 formulation Methods 0.000 abstract 2
229920002674 hyaluronan Polymers 0.000 abstract 2
229960003160 hyaluronic acid Drugs 0.000 abstract 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 abstract 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 abstract 1
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 abstract 1
240000008067 Cucumis sativus Species 0.000 abstract 1
235000010799 Cucumis sativus var sativus Nutrition 0.000 abstract 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
239000004472 Lysine Substances 0.000 abstract 1
239000005642 Oleic acid Substances 0.000 abstract 1
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 abstract 1
108010039918 Polylysine Proteins 0.000 abstract 1
244000028344 Primula vulgaris Species 0.000 abstract 1
235000016311 Primula vulgaris Nutrition 0.000 abstract 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 abstract 1
PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 abstract 1
150000001340 alkali metals Chemical class 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract 1
235000020661 alpha-linolenic acid Nutrition 0.000 abstract 1
235000021324 borage oil Nutrition 0.000 abstract 1
229940119217 chamomile extract Drugs 0.000 abstract 1
235000020221 chamomile extract Nutrition 0.000 abstract 1
229940009662 edetate Drugs 0.000 abstract 1
235000011187 glycerol Nutrition 0.000 abstract 1
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 abstract 1
239000004310 lactic acid Chemical class 0.000 abstract 1
235000014655 lactic acid Nutrition 0.000 abstract 1
235000010445 lecithin Nutrition 0.000 abstract 1
239000000787 lecithin Substances 0.000 abstract 1
229940067606 lecithin Drugs 0.000 abstract 1
229960004488 linolenic acid Drugs 0.000 abstract 1
KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 abstract 1
UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical class CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 abstract 1
235000019198 oils Nutrition 0.000 abstract 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 abstract 1
235000021313 oleic acid Nutrition 0.000 abstract 1
239000008177 pharmaceutical agent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
229920000656 polylysine Polymers 0.000 abstract 1
229960001860 salicylate Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229910021653 sulphate ion Inorganic materials 0.000 abstract 1
PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 abstract 1
229940117972 triolein Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Virology (AREA)
Zoology (AREA)
Biophysics (AREA)
Dispersion Chemistry (AREA)
Communicable Diseases (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Oncology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Neurosurgery (AREA)
Otolaryngology (AREA)
Rheumatology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)

AT99904638T 1998-02-10 1999-02-05 Mischmicell-arzneistoffverabreichungssystem und verfahren zu dessen herstellung ATE378062T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/021,114 US6017545A (en)	1998-02-10	1998-02-10	Mixed micellar delivery system and method of preparation
US09/216,733 US6231882B1 (en)	1998-02-10	1998-12-21	Mixed micellar delivery system and method of preparation

Publications (1)

Publication Number	Publication Date
ATE378062T1 true ATE378062T1 (de)	2007-11-15

Family

ID=21802420

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99904638T ATE378062T1 (de)	1998-02-10	1999-02-05	Mischmicell-arzneistoffverabreichungssystem und verfahren zu dessen herstellung

Country Status (12)

Country	Link
US (2)	US6017545A (de)
EP (1)	EP1053011B1 (de)
JP (1)	JP4499282B2 (de)
AT (1)	ATE378062T1 (de)
AU (1)	AU750197B2 (de)
BR (1)	BR9804295A (de)
DE (1)	DE69937546T2 (de)
DK (1)	DK1053011T3 (de)
ES (1)	ES2296380T3 (de)
NZ (1)	NZ506024A (de)
PT (1)	PT1053011E (de)
WO (1)	WO1999040932A1 (de)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2686899B1 (fr) *	1992-01-31	1995-09-01	Rhone Poulenc Rorer Sa	Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US7070799B1 (en) *	1998-02-10	2006-07-04	Generex Pharmaceuticals, Inc.	Method for administering insulin to the buccal region
AU763251B2 (en) *	1998-02-10	2003-07-17	Generex Pharmaceuticals Inc.	Mixed micellar pharmaceutical delivery system and method for preparation
US6350458B1 (en)	1998-02-10	2002-02-26	Generex Pharmaceuticals Incorporated	Mixed micellar drug deliver system and method of preparation
US6221378B1 (en) *	1998-02-10	2001-04-24	Generex Pharmaceuticals Incorporated	Mixed micellar delivery system and method of preparation
US6017545A (en) *	1998-02-10	2000-01-25	Modi; Pankaj	Mixed micellar delivery system and method of preparation
US6290987B1 (en) *	1998-09-27	2001-09-18	Generex Pharmaceuticals, Inc.	Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
US6193997B1 (en) *	1998-09-27	2001-02-27	Generex Pharmaceuticals Inc.	Proteinic drug delivery system using membrane mimetics
US6635617B1 (en) *	1998-10-16	2003-10-21	Novo Nordisk A/S	Insulin preparations for pulmonary delivery containing menthol
US6271200B1 (en) *	1998-12-21	2001-08-07	Generex Pharmaceuticals Inc.	Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles
US6436367B1 (en) *	1998-12-21	2002-08-20	Generex Pharmaceuticals Inc.	Aerosol formulations for buccal and pulmonary application
US7087215B2 (en) *	1998-12-21	2006-08-08	Generex Pharmaceuticals Incorporated	Methods of administering and enhancing absorption of pharmaceutical agents
US6849263B2 (en) *	1998-12-21	2005-02-01	Generex Pharmaceutical Incorporated	Pharmaceutical compositions for buccal delivery of pain relief medications
EP1338272A1 (de) *	1998-12-21	2003-08-27	Generex Pharmaceuticals Inc.	Aerosol Formulierungen für buccale und pulmonale Anwendung enthaltend Chenodeoxycholate oder Deoxycholate
US6451286B1 (en) *	1998-12-21	2002-09-17	Generex Pharmaceuticals Incorporated	Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
AU2006200276B2 (en) *	1998-12-21	2007-11-29	Generex Pharmaceuticals Inc.	Micellar pharmaceutical compositions for buccal and pulmonary application
US6294153B1 (en) *	1998-12-21	2001-09-25	Generex Pharmaceuticals, Inc.	Aerosol pharmaceutical formulation for pulmonary and nasal delivery
US6375975B1 (en) *	1998-12-21	2002-04-23	Generex Pharmaceuticals Incorporated	Pharmaceutical compositions for buccal and pulmonary application
US6312665B1 (en) *	1998-12-21	2001-11-06	Generex Pharmaceuticals Incorporated	Aerosol formulations for buccal and pulmonary application
US20040258763A1 (en) *	1999-02-03	2004-12-23	Bell Steve J.D.	Methods of manufacture and use of calcium phosphate particles containing allergens
DE60013773T2 (de)	1999-02-03	2005-11-10	Biosante Pharmaceuticals, Inc.	Methoden zur Herstellung von therapeutischen Kalziumphosphat Partikeln
US20020054914A1 (en) *	1999-02-03	2002-05-09	Tulin Morcol	Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
US7919109B2 (en)	1999-02-08	2011-04-05	Intarcia Therapeutics, Inc.	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en)	1999-02-08	2007-08-21	Alza Corporation	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US6350432B1 (en) *	1999-03-19	2002-02-26	Generex Pharmaceuticals Incorporated	Pressurized container having an aerosolized pharmaceutical composition
AU766745B2 (en) *	1999-03-19	2003-10-23	Generex Pharmaceuticals Inc.	Pharmaceutical solubilized in aerosol propellant
RU2155602C1 (ru)	1999-11-30	2000-09-10	Оао "Куантум Сатис"	Инсулинсодержащее лекарственное средство для перорального применения и способ его получения
AU4445201A (en) *	2000-03-30	2001-10-08	Generex Pharmaceuticals Inc.	Method for administering insulin to the buccal region
US6432383B1 (en) *	2000-03-30	2002-08-13	Generex Pharmaceuticals Incorporated	Method for administering insulin
JP2003530838A (ja) *	2000-04-12	2003-10-21	ヒューマンゲノムサイエンシズインコーポレイテッド	アルブミン融合タンパク質
US20050100991A1 (en) *	2001-04-12	2005-05-12	Human Genome Sciences, Inc.	Albumin fusion proteins
EP1301797A2 (de) *	2000-07-17	2003-04-16	Hansa Medical AB	Antimikrobielles mittel
DE10064219B9 (de)	2000-12-22	2009-02-12	Nasalis Pain Relief International Gmbh	Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung
ES2171147B1 (es) *	2001-02-06	2003-12-16	Esteve Labor Dr	Preparacion para usos veterinarios.
US20030064948A1 (en) *	2001-02-08	2003-04-03	Alfred Fahr	Invasomes for therapy of disorders, their preparation and use
US20060062855A1 (en) *	2001-02-27	2006-03-23	Bell Steve J D	Therapeutic calcium phosphate particles for use in inhibiting expression of a gene
US20020141970A1 (en) *	2001-03-05	2002-10-03	Pettit Dean K.	Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
CA2446739A1 (en) *	2001-05-25	2002-12-05	Human Genome Sciences, Inc.	Chemokine beta-1 fusion proteins
US20030096770A1 (en) *	2001-07-11	2003-05-22	Krotz Achim H.	Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants
AU2002364587A1 (en) *	2001-12-21	2003-07-30	Human Genome Sciences, Inc.	Albumin fusion proteins
ES2425738T3 (es) *	2001-12-21	2013-10-17	Human Genome Sciences, Inc.	Proteínas de fusión de la albúmina
DE60216242T2 (de) *	2002-06-06	2007-05-24	Chiesi Farmaceutici S.P.A.	Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen
US20040115226A1 (en) *	2002-12-12	2004-06-17	Wenji Li	Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
US7731947B2 (en)	2003-11-17	2010-06-08	Intarcia Therapeutics, Inc.	Composition and dosage form comprising an interferon particle formulation and suspending vehicle
DE10260882B4 (de) *	2002-12-24	2007-02-08	IG Sprühtechnik GmbH & Co. KG	Dosieraerosole mit Sojalecithin als oberflächenaktiver Substanz und dessen Verwendung
EP1594530A4 (de)	2003-01-22	2006-10-11	Human Genome Sciences Inc	Albuminfusionsproteine
US20050238632A1 (en) *	2004-04-23	2005-10-27	Alburty David S	Propellant formulations
WO2005105040A2 (en) *	2004-04-26	2005-11-10	Micelle Products, Inc.	Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
KR20050104152A (ko) *	2004-04-28	2005-11-02	최승호	경구용 약물의 흡수를 증진하는 약제학적 조성물
WO2006050368A2 (en)	2004-11-01	2006-05-11	Biosante Pharmaceuticals, Inc.	Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
TW200643033A (en) *	2005-03-08	2006-12-16	Chugai Pharmaceutical Co Ltd	Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue
NZ567601A (en) *	2005-11-30	2010-12-24	Generex Pharm Inc	Orally absorbed pharmaceutical formulation and method of administration
US20070264130A1 (en) *	2006-01-27	2007-11-15	Phluid, Inc.	Infusion Pumps and Methods for Use
WO2007140416A2 (en)	2006-05-30	2007-12-06	Intarcia Therapeutics, Inc.	Two-piece, internal-channel osmotic delivery system flow modulator
PT2359808E (pt)	2006-08-09	2013-08-28	Intarcia Therapeutics Inc	Sistemas de entrega osmótica e montagens de pistão
US20080146672A1 (en) *	2006-12-08	2008-06-19	Denton Marcia Marye	Topical Eutectic Anesthetic Composition for Oral or Dermal Tissue
ES2402172T3 (es)	2007-04-23	2013-04-29	Intarcia Therapeutics, Inc	Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
US8986253B2 (en) *	2008-01-25	2015-03-24	Tandem Diabetes Care, Inc.	Two chamber pumps and related methods
WO2009102467A2 (en)	2008-02-13	2009-08-20	Intarcia Therapeutics, Inc.	Devices, formulations, and methods for delivery of multiple beneficial agents
WO2009143188A2 (en) *	2008-05-19	2009-11-26	Diperna Paul M	Disposable pump reservoir and related methods
US8408421B2 (en) *	2008-09-16	2013-04-02	Tandem Diabetes Care, Inc.	Flow regulating stopcocks and related methods
CA2737461A1 (en) *	2008-09-19	2010-03-25	Tandem Diabetes Care, Inc.	Solute concentration measurement device and related methods
GB0904942D0 (en) *	2009-03-23	2009-05-06	Ntnu Technology Transfer As	Composition
US20110152770A1 (en) *	2009-07-30	2011-06-23	Tandem Diabetes Care, Inc.	Infusion pump system with disposable cartridge having pressure venting and pressure feedback
EP3735944A1 (de)	2009-09-28	2020-11-11	Intarcia Therapeutics, Inc.	Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
JP5892940B2 (ja)	2009-11-25	2016-03-23	アリスジェンソシエテアノニム	クラウン化合物及び／又は対イオンと複合体化されたペプチドを含む粘膜送達組成物
US20120201857A1 (en) *	2010-03-17	2012-08-09	Pankaj Modi	Transdermal delivery system for therapeutics
DE102010015350A1 (de)	2010-04-16	2011-10-20	Michael Zimmermann	Vaginalapplikator
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9180242B2 (en)	2012-05-17	2015-11-10	Tandem Diabetes Care, Inc.	Methods and devices for multiple fluid transfer
US9173998B2 (en)	2013-03-14	2015-11-03	Tandem Diabetes Care, Inc.	System and method for detecting occlusions in an infusion pump
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR102650751B1 (ko)	2015-06-03	2024-03-22	인타르시아 세라퓨틱스 인코포레이티드	임플란트 배치 및 제거 시스템들
CN109310743A (zh)	2016-05-16	2019-02-05	因塔西亚制药公司	胰高血糖素受体选择性多肽及其使用方法
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
AU2018206539A1 (en)	2017-01-03	2019-07-18	Intarcia Therapeutics, Inc.	Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
AU2019396217A1 (en) *	2018-12-10	2021-07-08	Halo Science LLC	Stable formulations of anesthetics and associated dosage forms
CN115154427B (zh) *	2022-08-15	2023-07-11	保定冀中药业有限公司	一种提高四黄止痢颗粒治疗湿热泻痢效果的制备方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US32393A (en) *		1861-05-21	Harrison Williams	Stop-motion for drawing-frames
US2055083A (en) *	1932-07-13	1936-09-22	Winthrop Chem Co Inc	Pharmaceutical preparation
DE1792410B2 (de)	1967-09-01	1980-03-13	Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm	Arzneimittelzubereitung zur intravenösen Injektion
US4464363A (en) *	1979-12-20	1984-08-07	Merck & Co., Inc.	Ajuvants for rectal delivery of drug substances
DE3171774D1 (en) *	1980-03-31	1985-09-19	Teijin Ltd	Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
US4900730A (en) *	1981-01-14	1990-02-13	Toyo Jozo Co., Ltd.	Preparation which promotes the absorption of peptides
NL193099C (nl) *	1981-10-30	1998-11-03	Novo Industri As	Gestabiliseerde insuline-oplossing.
US4963367A (en) *	1984-04-27	1990-10-16	Medaphore, Inc.	Drug delivery compositions and methods
US4849405A (en) *	1984-05-09	1989-07-18	Synthetic Blood Corporation	Oral insulin and a method of making the same
US4963526A (en) *	1984-05-09	1990-10-16	Synthetic Blood Corporation	Oral insulin and a method of making the same
JPS61267528A (ja) *	1984-11-26	1986-11-27	Yamanouchi Pharmaceut Co Ltd	吸収促進剤を含有するカルシトニン経鼻剤
EP0200383A3 (de) *	1985-04-15	1987-09-02	Eli Lilly And Company	Verfahren zur Verabreichung von Insulin
US4973579A (en) *	1985-06-28	1990-11-27	Merck & Co., Inc.	Enhancment of absorption of drugs from gastrointestinal tract using choline ester salts
US4822773A (en) *	1985-06-28	1989-04-18	Merck & Co., Inc.	Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts
US4729989A (en) *	1985-06-28	1988-03-08	Merck & Co., Inc.	Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts
US4692441A (en) *	1985-08-16	1987-09-08	Merck & Co., Inc.	Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities
US4963556A (en) *	1985-08-16	1990-10-16	Merck & Co., Inc.	Choline esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities
NZ222907A (en) *	1986-12-16	1990-08-28	Novo Industri As	Preparation for intranasal administration containing a phospholipid absorption enhancing system
US5179079A (en) *	1986-12-16	1993-01-12	Novo Nordisk A/S	Nasal formulation and intranasal administration therewith
US5690954A (en) *	1987-05-22	1997-11-25	Danbiosyst Uk Limited	Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
GB8822857D0 (en) *	1988-09-29	1988-11-02	Patralan Ltd	Pharmaceutical formulations
KR0157428B1 (ko) *	1989-02-17	1998-11-16	알렌 불룸	비 전달용 지질부형제와 그 사용법
US5109118A (en) *	1989-07-06	1992-04-28	Yutaka Mizushima	Modified biologically active proteins
CA1340994C (en) *	1989-09-21	2000-05-16	Rudolf Edgar Dr. Falk	Treatment of conditions and disease
CA2033725C (en) *	1990-01-24	2001-05-29	Folker Pittrof	Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
GB9007052D0 (en) *	1990-03-29	1990-05-30	Skua Investments Ltd	Pharmaceutical formulations
GB9012663D0 (en) *	1990-06-07	1990-08-01	Erba Carlo Spa	Galenic formulations containing cyclodextrins
US5230884A (en) *	1990-09-11	1993-07-27	University Of Wales College Of Cardiff	Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
US5416071A (en) *	1991-03-12	1995-05-16	Takeda Chemical Industries, Ltd.	Water-soluble composition for sustained-release containing epo and hyaluronic acid
CA2108266C (en) *	1991-04-19	2003-06-03	Albert J. Owen	Convertible microemulsion formulations
US5292489A (en) *	1991-06-24	1994-03-08	Alliedsignal Inc.	Ternary silicon-rare earth nitrides and process for their preparation
GB9202464D0 (en) *	1992-02-05	1992-03-18	Danbiosyst Uk	Composition for nasal administration
CA2094217A1 (en) *	1992-04-17	1993-10-18	Yasutaka Igari	Transmucosal therapeutic composition
IL109350A (en) *	1993-05-12	2001-01-28	Genentech Inc	Stable liquid compositions of gamma interferon
US5576016A (en) *	1993-05-18	1996-11-19	Pharmos Corporation	Solid fat nanoemulsions as drug delivery vehicles
US5506203C1 (en) *	1993-06-24	2001-02-06	Astra Ab	Systemic administration of a therapeutic preparation
DE4323636A1 (de) *	1993-07-15	1995-01-19	Hoechst Ag	Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
US5424289A (en) *	1993-07-30	1995-06-13	Alza Corporation	Solid formulations of therapeutic proteins for gastrointestinal delivery
US5514670A (en) *	1993-08-13	1996-05-07	Pharmos Corporation	Submicron emulsions for delivery of peptides
DK0743851T3 (da) *	1994-02-04	2001-09-03	Lipocore Holding Ab	Lipofile bærepræparater
US5447729A (en) *	1994-04-07	1995-09-05	Pharmavene, Inc.	Multilamellar drug delivery systems
US5451569A (en) *	1994-04-19	1995-09-19	Hong Kong University Of Science And Technology R & D Corporation Limited	Pulmonary drug delivery system
US5574017A (en) *	1994-07-05	1996-11-12	Gutheil; William G.	Antibacterial agents
US6524557B1 (en) *	1994-12-22	2003-02-25	Astrazeneca Ab	Aerosol formulations of peptides and proteins
US5653987A (en) *	1995-05-16	1997-08-05	Modi; Pankaj	Liquid formulations for proteinic pharmaceuticals
US6017545A (en) *	1998-02-10	2000-01-25	Modi; Pankaj	Mixed micellar delivery system and method of preparation

1998
- 1998-02-10 US US09/021,114 patent/US6017545A/en not_active Expired - Lifetime
- 1998-10-27 BR BR9804295-5A patent/BR9804295A/pt not_active IP Right Cessation
- 1998-12-21 US US09/216,733 patent/US6231882B1/en not_active Expired - Fee Related
1999
- 1999-02-05 DK DK99904638T patent/DK1053011T3/da active
- 1999-02-05 AU AU25053/99A patent/AU750197B2/en not_active Revoked
- 1999-02-05 PT PT99904638T patent/PT1053011E/pt unknown
- 1999-02-05 ES ES99904638T patent/ES2296380T3/es not_active Expired - Lifetime
- 1999-02-05 WO PCT/CA1999/000106 patent/WO1999040932A1/en not_active Ceased
- 1999-02-05 DE DE69937546T patent/DE69937546T2/de not_active Expired - Lifetime
- 1999-02-05 NZ NZ506024A patent/NZ506024A/en not_active IP Right Cessation
- 1999-02-05 AT AT99904638T patent/ATE378062T1/de active
- 1999-02-05 EP EP99904638A patent/EP1053011B1/de not_active Expired - Lifetime
- 1999-02-05 JP JP2000531183A patent/JP4499282B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP2003522096A (ja)	2003-07-22
AU2505399A (en)	1999-08-30
WO1999040932A1 (en)	1999-08-19
DE69937546T2 (de)	2008-05-29
DK1053011T3 (da)	2008-03-25
JP4499282B2 (ja)	2010-07-07
EP1053011A1 (de)	2000-11-22
NZ506024A (en)	2002-02-01
PT1053011E (pt)	2008-02-14
WO1999040932A9 (en)	2000-03-30
AU750197B2 (en)	2002-07-11
DE69937546D1 (de)	2007-12-27
EP1053011B1 (de)	2007-11-14
ES2296380T3 (es)	2008-04-16
US6231882B1 (en)	2001-05-15
US6017545A (en)	2000-01-25
BR9804295A (pt)	2000-03-28

Legal Events

Date

Code

Title

Description

2008-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1053011

Country of ref document: EP

Publication	Publication Date	Title
ATE378062T1 (de)	2007-11-15	Mischmicell-arzneistoffverabreichungssystem und verfahren zu dessen herstellung
CA2382535A1 (en)	2001-03-08	Mixed micellar pharmaceutical delivery system and method of preparation
NZ512188A (en)	2002-10-25	Micelle aerosol formulations for buccal and pulmonary application
ATE202698T1 (de)	2001-07-15	Topisch applizierbare pharmazeutische zusammensetzung, verfahren zu ihrer herstellung und verwendung der zusammensetzung
EP0391369A3 (de)	1991-04-24	Arzneiemulsionen
ATE179886T1 (de)	1999-05-15	Pharmazeutische zusammensetzung mit einem schmelzbaren traegermaterial und verfahren zu seiner herstellung
DE59002618D1 (de)	1993-10-14	Verfahren zur Herstellung einer Nanoemulsion von Oelpartikeln in einer wässrigen Phase.
ATE307569T1 (de)	2005-11-15	Gelierbare pharmazeutische zusammensetzungen
SI1313510T1 (en)	2005-04-30	Injectable pharmaceutical composition for systemic delivery of pharmacologically active compounds comprising medium chain triglycerides
EP0783299A4 (de)	1999-06-30	Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
DE59510233D1 (de)	2002-07-11	Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
ATE203392T1 (de)	2001-08-15	Stabilisierte pseudoemulsionen und verfahren zu ihrer herstellung
WO2001072278A3 (en)	2002-04-11	Method for administering insulin to the buccal region
EP1219288A3 (de)	2003-07-30	Zusammensetzung zur Hautbehandlung
ATE226428T1 (de)	2002-11-15	Verfahren zur herstellung von pharmazeutischen zusammensetzungen
CA2229286A1 (en)	1999-08-10	Mixed micellar delivery system and method of preparation
KR940013503A (ko)	1994-07-15	동맥경화증의 예방 또는 치료용 약제학적 조성물
NZ332497A (en)	1999-05-28	Pharmaceutical composition having a carrier system containing a combination of an alkylene glycol and unsaturated fatty acid alcohol as the solvent and a stiffening agent
ATE160938T1 (de)	1997-12-15	Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung
JPH0948962A (ja)	1997-02-18	液体の固化抑制剤
NZ514319A (en)	2002-11-26	Proteinic pharmaceutical agent solubilized in aerosol propellant in a pressurized container
ATE212840T1 (de)	2002-02-15	Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
IE61287B1 (en)	1994-10-19	Pharmaceutical composition for the transdermal application of herparin
JPS57109713A (en)	1982-07-08	Pharmaceutical preparation of combined agent of sulfamethoxazole and trimethoprim for medication through celom
CN1101668A (zh)	1995-04-19	高效防油类护肤去污剂及制造方法